Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03691038
Other study ID # 2018-08-013
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date October 10, 2018
Est. completion date October 30, 2019

Study information

Verified date September 2020
Source Kangbuk Samsung Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to propose a new flexible dose regimen starting from 75mg using the low dose pregabalin 25 mg and 50 mg comparing the side effect and compliance with the conventional flexible dose regimen staring from 150mg using the pregabalin 75mg.


Description:

Pregabalin has been shown to be effective as a first-line medication for neuropathic pain but it appears to have several side effects such as dizziness, drowsiness, and edema, which lowers compliance with medications. A way to reduce side effects is the flexible dose regimen, which reaches the target dose to treat the drug. The proposed flexible dose regimen is a regimen that begins with twice the prevalence of 75 mg. However, dizziness is the most common side effect up to 20% in conventional flexible dose regimen. Therefore, the aim of this study was to propose a new flexible regimen starting at a dose less than the existing dose and to compare compliance with pregabaline according to both methods


Recruitment information / eligibility

Status Terminated
Enrollment 10
Est. completion date October 30, 2019
Est. primary completion date October 30, 2019
Accepts healthy volunteers No
Gender All
Age group 19 Years to 85 Years
Eligibility Inclusion Criteria:

- Pain score NRS =3 Patients complaining of neuropathic pain (except neuropathic pain due to chemotherapy)

- Adult patients aged 19 to 85 years

- Patients who pre-agreed to the study

Exclusion Criteria:

- Patients complaining of severe pain (NRS = 8)

- Creatinine clearance of <30 mL / min, the liver was more than 3 times normal

- Patients complaining of dizziness, patients with definite orthostatic hypotension

- Pregnant or lactating patients

- Patients who previously experienced side effects after administration pregabalin.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Pregabalin 75mg bid
Through the study period, Incremental protocol follows the conventional dose regimen starting pregabaline 75mg bid.
Pregabalin 25mg, 50mg
Through the study period, Incremental protocol follows the new dose regimen starting pregabalin 25mg, 50mg

Locations

Country Name City State
Korea, Republic of Kangbuk Samsung Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Kangbuk Samsung Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary discontinuation of medication the portion of patients discontinuing medication After 7 weeks of prescription
See also
  Status Clinical Trial Phase
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Completed NCT03280017 - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain Phase 4
Enrolling by invitation NCT04097015 - Using NI-ES to Treat Spinal Cord Injury (SCI) N/A
Not yet recruiting NCT04585620 - Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery Phase 1/Phase 2
Completed NCT04371575 - Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients
Completed NCT03723447 - Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Phase 4
Completed NCT01485185 - Gabapentin and Donepezil Combination on Experimental Human Pain Models Phase 1
Completed NCT04375436 - Safety and Tolerability of NTRX-07 in Healthy Volunteers Phase 1
Completed NCT03674489 - Local and Widespread Hypoalgesic Effects of Neurodynamic Mobilization in Healthy Controls N/A
Recruiting NCT04299893 - Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) Phase 2/Phase 3
Recruiting NCT03618589 - Pregabalin add-on for Neuropathic Pain in Cervical Myelopathy Phase 1
Completed NCT04625504 - Investigating Biological Targets, Markers, and Intervention for Chronic Pain N/A
Recruiting NCT04622904 - Lidocaine and Magnesium and Ketamine in Gynecological Surgery N/A
Recruiting NCT06062108 - Prevalence of Pain in Hospitalized Cirrhotic Patients
Recruiting NCT04718116 - Tapentadol Versus Tramadol Analgesia Post Cardiac Surgery N/A
Recruiting NCT04909593 - Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial N/A
Recruiting NCT05243940 - Opioid-free Anesthesia in Thyroidectomies N/A
Recruiting NCT05349448 - Can Dexmedetomidine With Hyalase Augment Quality and Duration of Analgesia When Added to Lumbar Epidural Steroid in Failed Back Surgery. Randomized Double Blind Study Early Phase 1
Withdrawn NCT03747562 - Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. Phase 3